Primary study · included by 1 review

Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.

Klein Hesselink 2016 · Klein Hesselink Esther N, Brouwers Adrienne H, de Jong Johan R, et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2016

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.

Non-Cochrane · prognostic · 2026 · cited as Klein Hesselink 2016 · Supplementary Table S3 (included studies); Figs. 1-3

Outcome this study informs	Pooled effect	Evidence	Certainty
Xerostomia (pooled prevalence) Radioiodine (I131) therapy · between 2 and 6 months after RIT	Prevalence 0.37 [0.28, 0.47]	4 studies · 392 participants	GRADE not reported

1 including review in total.